• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康志愿者和α1-抗胰蛋白酶缺乏症患者的患者自主连续肺活量测定法

Patient-administered sequential spirometry in healthy volunteers and patients with alpha 1-antitrypsin deficiency.

作者信息

Madsen F, Ulrik C S, Dirksen A, Hansen K K, Nielsen N H, Frølund L, Viskum K, Kok-Jensen A

机构信息

Department of Pulmonary Medicine, Rigshospitalet, Copenhagen, Denmark.

出版信息

Respir Med. 1996 Mar;90(3):131-8. doi: 10.1016/s0954-6111(96)90154-7.

DOI:10.1016/s0954-6111(96)90154-7
PMID:8736204
Abstract

The launching of cheap, pocket-sized spirometers, with data storage capability, has made patient-administered sequential spirometry (PASS) an attractive method of monitoring ventilatory capacity. At present, little information is available on the quality of PASS, compared to laboratory spirometry. The aim of this study was to investigate whether patients could perform PASS without loss of reliability and reproducibility as compared with traditional laboratory spirometry. Ten healthy volunteers performed spirometry for 1 month and 10 emphysematous patients with alpha 1-antitrypsin deficiency (type PiZ) performed spirometry twice daily for up to 2 yr. To fulfil Good Clinical Practice criteria on full data documentation, a traditional direct recording spirometer, the Vitalograph R-model, was used. A decompression device was used for calibration and a 3.8% annual drift in volume registration was noted. This drift was largest for the first year. After training, all patients were able to perform unsupervised spirometry, producing technically correct forced expiratory curves. Reproducibility of FEV1 and FVC obtained by PASS was found to be as good as for laboratory spirometry. After adjustment for the diurnal variation, the residual variation of FEV1 was 2.5% (range 1.6-4.2%) for healthy volunteers and 5.6% (range 4.2-7.7%) for emphysematous patients. Forced vital capacity showed the same pattern. In conclusion, PASS is possible in highly motivated individuals without loss of reliability and reproducibility when compared to laboratory spirometry.

摘要

具备数据存储功能的廉价袖珍肺活量计的推出,使患者自行进行的连续肺活量测定(PASS)成为一种颇具吸引力的通气功能监测方法。目前,与实验室肺活量测定相比,关于PASS质量的信息较少。本研究的目的是调查与传统实验室肺活量测定相比,患者进行PASS时是否会丧失可靠性和可重复性。10名健康志愿者进行了1个月的肺活量测定,10名α1抗胰蛋白酶缺乏症(PiZ型)的肺气肿患者每天进行两次肺活量测定,持续长达2年。为符合完整数据记录的良好临床实践标准,使用了传统的直接记录式肺活量计Vitalograph R型。使用减压装置进行校准,发现体积记录存在3.8%的年度漂移。第一年这种漂移最大。经过培训后,所有患者都能够在无人监督的情况下进行肺活量测定,生成技术上正确的用力呼气曲线。发现PASS获得的FEV1和FVC的可重复性与实验室肺活量测定一样好。在对昼夜变化进行调整后,健康志愿者FEV1的残余变化为2.5%(范围1.6 - 4.2%),肺气肿患者为5.6%(范围4.2 - 7.7%)。用力肺活量呈现相同模式。总之,对于积极性高的个体,与实验室肺活量测定相比,进行PASS是可行的,且不会丧失可靠性和可重复性。

相似文献

1
Patient-administered sequential spirometry in healthy volunteers and patients with alpha 1-antitrypsin deficiency.健康志愿者和α1-抗胰蛋白酶缺乏症患者的患者自主连续肺活量测定法
Respir Med. 1996 Mar;90(3):131-8. doi: 10.1016/s0954-6111(96)90154-7.
2
Long-term performance of a hand held spirometer.手持式肺活量计的长期性能
Thorax. 1996 Oct;51(10):973-6. doi: 10.1136/thx.51.10.973.
3
The utility of hand-held mobile spirometer technology in a resource-constrained setting.手持式移动肺量计技术在资源有限环境下的实用性。
S Afr Med J. 2019 Mar 29;109(4):219-222. doi: 10.7196/SAMJ.2019.v109i4.13845.
4
The effect of inhaled glucocorticosteroids in emphysema due to alpha1-antitrypsin deficiency.吸入性糖皮质激素对α1-抗胰蛋白酶缺乏所致肺气肿的影响。
Respir Med. 1997 May;91(5):275-9. doi: 10.1016/s0954-6111(97)90030-5.
5
Standardization of different spirometers.不同肺活量计的标准化
Respiration. 1988;53(1):58-63. doi: 10.1159/000195397.
6
A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy.α1抗胰蛋白酶增强疗法的一项随机临床试验。
Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1468-72. doi: 10.1164/ajrccm.160.5.9901055.
7
Long-range correlations of serial FEV1 measurements in emphysematous patients and normal subjects.肺气肿患者和正常受试者连续用力呼气容积(FEV1)测量值的长期相关性。
J Appl Physiol (1985). 1998 Jul;85(1):259-65. doi: 10.1152/jappl.1998.85.1.259.
8
Lung clearance index for monitoring early lung disease in alpha-1-antitrypsin deficiency.用于监测α-1抗胰蛋白酶缺乏症早期肺部疾病的肺清除指数
Respir Med. 2016 Jul;116:93-9. doi: 10.1016/j.rmed.2016.04.015. Epub 2016 Apr 27.
9
A comparison of a new transtelephonic portable spirometer with a laboratory spirometer.一种新型经电话传输的便携式肺活量计与实验室肺活量计的比较。
Eur Respir J. 1999 Jul;14(1):209-13. doi: 10.1034/j.1399-3003.1999.14a35.x.
10
Pocket-sized device for measuring forced expiratory volume in one second and forced vital capacity.用于测量一秒用力呼气量和用力肺活量的袖珍设备。
Br Med J (Clin Res Ed). 1982 Jul 3;285(6334):15-7. doi: 10.1136/bmj.285.6334.15.

引用本文的文献

1
Remote Patient Monitoring for the Detection of COPD Exacerbations.用于检测慢性阻塞性肺疾病急性加重的远程患者监测
Int J Chron Obstruct Pulmon Dis. 2020 Aug 24;15:2005-2013. doi: 10.2147/COPD.S256907. eCollection 2020.
2
Statistical Process Control Improves The Feasibility Of Remote Physiological Monitoring In Patients With Chronic Obstructive Pulmonary Disease.统计过程控制提高了慢性阻塞性肺疾病患者远程生理监测的可行性。
Int J Chron Obstruct Pulmon Dis. 2019 Nov 13;14:2485-2496. doi: 10.2147/COPD.S207626. eCollection 2019.
3
COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?
在一般实践中为 COPD 患者开吸入皮质类固醇的处方:根据指南的疾病特征?
Chron Respir Dis. 2019 Jan-Dec;16:1479973119867949. doi: 10.1177/1479973119867949.
4
Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病(COPD)患者全科医疗人群中肺量计测试的有效性。
Thorax. 2003 Oct;58(10):861-6. doi: 10.1136/thorax.58.10.861.
5
Long-term performance of a hand held spirometer.手持式肺活量计的长期性能
Thorax. 1996 Oct;51(10):973-6. doi: 10.1136/thx.51.10.973.